In this Wall Street Journal Think Tank column Drew Altman discusses how Republicans will assume ownership of health care’s policy and political problems as they assume control, and how that may affect their plans for the Affordable Care Act, Medicaid and Medicare.
- view as grid
- view as list
This column was published as a Wall Street Journal Think Tank column on November 21, 2016. Early media coverage of the Republican health-care agenda has concentrated on plans to repeal and then replace the Affordable Care Act. The larger story is GOP preparations for a health policy trifecta: to fundamentally change the…
This blog post revisits an earlier analysis of the drug Sovaldi (sofosbuvir) using new data released by the Centers for Medicare and Medicaid Services, and considers both the ongoing impact of hepatitis C drugs for Medicare Part D and the broader implications for Medicare of new high-priced drugs entering the market.
In this Wall Street Journal Think Tank column, Drew Altman discusses why the real moment of truth in assessing the stability of the Affordable Care Act’s health care Marketplaces may come next spring.
In this post for The JAMA Forum, the Kaiser Family Foundation’s Larry Levitt discusses the concept of allowing insurers to sell health plans across state lines and how such a proposal could affect people with pre-existing conditions.
This column was published as a Wall Street Journal Think Tank column on October 12, 2016. U.S. Uninsured Rate is At An All-Time Low, But The Public Doesn’t Know It Donald Trump derided the Affordable Care Act in the second presidential debate as a “total disaster.” One inarguable success…
The leading US presidential candidates and their parties’ platforms offer distinct and often opposing policy proposals on issues that affect women’s health. In the Women’s Health Issues journal, the Kaiser Family Foundation’s Caroline Rosenzweig, Usha Ranji, and Alina Salganicoff present their analysis of the differences between the Democratic and Republican parties on range of women’s health policy issues – including the Affordable Care Act, reproductive health, older women’s health, and violence prevention.
In this Wall Street Journal Think Tank column, Drew Altman uses findings from a new KFF/CNN survey of working-class white Americans and from Pew Research to examine xenophobia in America in a time of Trump.
This policy insight examines the Hyde Amendment, an annually approved law that bans the use of federal funds to pay for abortions unless the pregnancy is a result of rape, incest, or endangerment of the life of a woman. The Hyde Amendment has become the focus of debate in the 2016 presidential election. Hillary Clinton is the first presidential candidate to openly support lifting the Hyde bans on federal funding for abortion, while Donald Trump recently endorsed the codification of the law and established a Pro-life coalition. This perspective details the federal programs that are affected by the Hyde Amendment, provides estimates on the share of women insured by Medicaid affected by the law, the impact on their access to abortion services, and the potential effect if the law were to be repealed or codified.
This policy insight examines the low rate of Medigap coverage among people under age 65 with disabilities on Medicare and the federal law that governs consumer rights and protections related to Medigap open enrollment.